» Authors » Robert P Hoffman

Robert P Hoffman

Explore the profile of Robert P Hoffman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 1237
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Hoffman R, Copenhaver M, Zhou D, Yu C
J Pediatr Endocrinol Metab . 2021 Apr; 34(5):599-605. PMID: 33818037
Objectives: In obese adults the shape of the glucose response curve during an oral glucose tolerance test (OGTT) predicts future type 2 diabetes. Patients with an incessant increase or monophasic...
12.
Ahmad H, Al-Hadidi A, Bobbey A, Shah S, Stanek J, Nicol K, et al.
J Pediatr Surg . 2021 Mar; 56(6):1120-1125. PMID: 33745740
Background/purpose: Thyroid Imaging Reporting and Data System (TI-RADS) is validated in adults but not yet in children. The purpose of this study was to determine the sensitivity, specificity, and accuracy...
13.
Guarneri A, Hoffman R
Curr Diabetes Rev . 2021 Jan; 18(2):e012821190877. PMID: 33511950
Insulin is primarily considered for its glycemic effects in patients with diabetes. There are, however, non-glycemic adverse effects of insulin that may significantly impact patient health and interfere with glycemic...
14.
Faulds E, Hoffman R, Grey M, Tan A, Tubbs-Cooley H, Militello L, et al.
Pediatr Diabetes . 2020 Sep; 21(8):1525-1536. PMID: 32985060
Objective: Despite increased diabetes device use, few adolescents with type 1 diabetes (T1D) meet glycemic targets. We examine associations between utilization of insulin pumps and continuous glucose monitoring (CGM) and...
15.
Copenhaver M, Yu C, Zhou D, Hoffman R
Pediatr Res . 2019 Aug; 87(1):88-94. PMID: 31404919
Background: Complement promotes inflammatory and immune responses and may affect cardiometabolic risk. This study was designed to investigate the effect of complement components C3 and C4 on cardiometabolic risk in...
16.
Hoffman R, Copenhaver M, Zhou D, Yu C
Pediatr Diabetes . 2019 Jul; 20(7):842-848. PMID: 31329355
Background: Cardiovascular disease has its origins in adolescents. Endothelial dysfunction, arterial stiffness, and decreased endocardial oxygen supply: demand ratios are early functional markers of cardiovascular risk. The goal of this...
17.
Obrynba K, Hoffman R, Repaske D, Anglin K, Kamboj M
J Pediatr Endocrinol Metab . 2018 Jul; 31(7):809-814. PMID: 29959886
Background Individuals with Prader-Willi syndrome (PWS) have hypothalamic dysfunction and may have central adrenal insufficiency (CAI). The prevalence of CAI in PWS remains unknown. Methods Twenty-one subjects with PWS aged...
18.
Copenhaver M, Yu C, Hoffman R
Curr Diabetes Rev . 2018 Apr; 15(1):44-48. PMID: 29663892
Introduction: Increased systemic inflammation plays a significant role in the development of adult cardiometabolic diseases such as insulin resistance, dyslipidemia, atherosclerosis, and hypertension. The complement system is a part of...
19.
Glick B, Hong K, Obrynba K, Kamboj M, Hoffman R
J Pediatr Endocrinol Metab . 2018 Jan; 31(1):39-44. PMID: 29303779
Background: This study was designed to determine the effects of diabetes type and gender on depression risk determined by a highly sensitive screening questionnaire in adolescents. Glycemic control and counseling...
20.
Copenhaver M, Hoffman R
Transl Pediatr . 2017 Nov; 6(4):359-364. PMID: 29184816
Type 1 diabetes mellitus is a chronic state of insulin deficiency which results from destruction of beta cells by the immune system. The long term microvascular and macrovascular complications can...